A new feature in Clinical Leader highlights Cognixion’s ongoing feasibility study of the Axon-R™ non-invasive brain-computer interface headset and the Nucleus™ bio-sensing hub. The study explores how combinations of brain signals, eye tracking, and AI can support communication for people with ALS and other conditions that affect speech.
In the interview, Cognixion CTO Chris Ullrich discusses how the Axon-R and Nucleus platform integrates with Apple Vision Pro, the role of patient and caregiver feedback in shaping the system, and the importance of responsible clinical and regulatory development. The focus is on creating a communication pathway that is intuitive, adaptable, and designed to meet real-world needs.
Read the full story on Clinical Leader:
Non-Invasive Brain-Computer Interface Trial Balances Regulatory Requirements With Patient Needs